Gland Pharma Dividend & Ex-dividend History

GLAND • Dividend Analysis
Latest Dividend
₹20.0
0.59% Yield • 2026-March
Annual Payment

Gland Pharma dividend history & ex-dividend dates. Gland Pharma (GLAND) has paid dividends for 3 years, annual, with a current yield of 0.61% and an average yield of 0.97% (30.0% consistency). The last dividend was ₹20.0 per share (2026-March, 0.59% yield), peak yield 1.26%. For the full company profile including live price and ratios, see GLAND stock price BSE.

Dividend Data Export

Dividend Summary

Latest Dividend ₹20.0
Average Dividend ₹19.33

Gland Pharma Dividend Per Share & Yield History

GLAND annual dividend per share (DPS) and dividend yield over 3 years. View GLAND annual price range for the annual high/low range and current price position.

Gland Pharma Dividend Payment History

GLAND ex-dividend dates, dividend per share, yield and payment type — 10 records. See Gland Pharma P/B valuation to compare market price against book value per share.

Year Period Dividend per Share Dividend Yield Payment Type
2026 March ₹20.00 0.59% Annual
2025 March ₹18.00 1.06% Annual
2024 March ₹20.00 1.26% Annual
2023 March ₹0.00 0.00% Annual
2022 March ₹0.00 0.00% Annual
2021 March ₹0.00 0.00% Annual
2020 March ₹0.00 0.00% Annual
2019 March ₹0.00 0.00% Annual
2018 March ₹0.00 0.00% Annual
2017 March ₹0.00 0.00% Annual

Frequently Asked Questions

Q: How much dividend does Gland Pharma pay?

Gland Pharma last paid a dividend of ₹20.0 with a yield of 0.59%. The company typically pays dividends annual.

Q: What is Gland Pharma dividend yield?

Gland Pharma has an average dividend yield of 0.97% based on historical data. The highest yield recorded was 1.26% and the lowest was 0.59%.

Q: How often does Gland Pharma pay dividends?

Gland Pharma typically pays dividends annual. The company has maintained a consistent payment frequency.

Q: Is Gland Pharma a good dividend stock?

Gland Pharma has paid dividends with 30.0% consistency over 10 years. The company has paid dividends in 3 out of 10 years tracked. Consider this alongside your investment goals and risk tolerance.